secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001104659-23-106030
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals raises $5.0M in registered direct offering with warrants
-------------------------------------------------------------------------------

- Gross proceeds $5.0M from sale of 980,393 shares (or equivalents) at $5.10/share plus warrants.
- Series A and B warrants to buy up to 980,393 shares each at $4.85; Series A expires in 5 yrs, Series B in 1.5 yrs.
- Closing expected on or about Oct 3, 2023; A.G.P./Alliance Global Partners as placement agent.
- Net proceeds intended for clinical development and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923106030/0001104659-23-106030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923106030/tm2327415d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-106030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer